Vaso Active Pharmaceuticals, Inc. is a company focused on commercializing,
marketing and selling over-the-counter (OTC) pharmaceutical products. Vaso ...
Sep 1, 2000 ... (1)Millennium Pharmaceuticals, Inc, Cambridge, MA 02139, USA. ... of key
vasoactive peptides suggest an essential role for ACE2 in the local ...
ganglion (SCG) of the adult rat (Hokfelt et al., 1977; Sasek and. Zigmond, 1989).
... synthesis, depolarization of sympathetic neurons has been re- ported to inhibit
the .... by adding 1.5 PM veratridine (ICN Pharmaceuticals Inc., Plainview,. NY).
vasoactive agents may interact to relax arterial smooth muscle. These results
may have ... lings et aL, 1969; Sybers et al., 1971) and adenosine. (Berne, 1963 ...
Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of
severe ... Park et al.  evaluated the clinical response and the haemodynamic ...
ultrasonography (CDUS), using a Model SSA-350 A system (Toshiba Inc., Tokyo,
... mL containing 10 mg phentolamine, Novartis Pharma AG, Basel, Switzerland).
Dec 22, 2015 ... ... Asahi Kasei Pharma [sepsis with coagulopathy (ART-13)]; Ferring, Inc [septic
shock (terlipressin)]. ... hypotension, reliance on vasoactive drug administration to
maintain a normal ...... Menon K, Ward RE, Lawson ML, et al.
Apr 23, 2015 ... <sup>10</sup>GlycoMimetics, Inc., Gaithersburg, MD ... Treatment of vaso-occlusive crises (
VOC) or events in sickle cell ..... for both the active drug and placebo groups, as
did total IV opioid use. .... Piel FB,; Patil AP,; Howes RE,; et al.
flammatory cytokines such as IL-6 and TNF (11–13), to re- duce the expression of
the .... and H89 was from ICN Pharmaceuticals Inc (Costa Mesa, CA). Anti-
bodies against .... pared by the mini-extraction procedure of Schreiber et al. (40)
Vasoactive intestinal peptide (VIP) and the structurally re- lated peptide, the ...
from ICN Pharmaceuticals Inc. (Costa Mesa, CA). rIκBα (1–317) .... Delgado et al.
Jul 7, 2009 ... heart failure while lacking the vasoactive properties of BNP. These findings ...
Genome-wide analyses have revealed the prevalence of al- ternative .... Pan et al
. PNAS. July 7 ... As alternative splicing usually affects coding re- .... BNP (hBNP,
Phoenix Pharmaceuticals, Inc.) or ASBNP.1 (final concentration.